215 related articles for article (PubMed ID: 22381170)
1. Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.
Li W; Wang X; Chen R; Zhu H; Chen G; Sun X
J Surg Res; 2012 Aug; 176(2):e79-87. PubMed ID: 22381170
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells transfected with PD-L1 recombinant adenovirus induces T cell suppression and long-term acceptance of allograft transplantation.
Peng W; Ran B; Ma Y; Huang X; Chang Q; Wang X
Cell Immunol; 2011; 271(1):73-7. PubMed ID: 21855860
[TBL] [Abstract][Full Text] [Related]
3. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
[TBL] [Abstract][Full Text] [Related]
4. A novel pseudovirus containing lewis X oligosaccharides with pD-L1 targeting to DCs induces T cells tolerance.
Wang X; Yang X; Cui S; Yan Y; Yang Z
Transplantation; 2009 May; 87(9):1305-7. PubMed ID: 19424029
[TBL] [Abstract][Full Text] [Related]
5. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
Gao W; Demirci G; Strom TB; Li XC
Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
[TBL] [Abstract][Full Text] [Related]
6. DCs sensitized with mPD-L1-Ig fusion protein improve the effect of heart transplantation in mice by promoting the generation of T-reg cells.
Liu C; Chen H; Jia J; Hong T; Wang C
Cell Immunol; 2014 Jul; 290(1):169-77. PubMed ID: 24997656
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of NIT-1 cells expressing pD-L1 for treatment of streptozotocin-induced diabetes.
Wen X; Zhu H; Li L; Li Y; Wang M; Liu J; Yang D; Liao W; Shen G
Transplantation; 2008 Dec; 86(11):1596-602. PubMed ID: 19077895
[TBL] [Abstract][Full Text] [Related]
8. Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells.
Chen C; Qu QX; Huang JA; Zhu YB; Ge Y; Wang Q; Zhang XG
Immunobiology; 2007; 212(3):159-65. PubMed ID: 17412283
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of programmed death-1 ligand-1 on NIT cells lead to negative regulation of allogeneic lymphocyte activation.
Wen X; Xu G; Liu J; Zhu H; Dai H; Li L; Hong Y; Yang J; Dai W; Ping L; Shen G
Cell Immunol; 2010; 263(1):122-8. PubMed ID: 20381020
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 blockade improves immune dysfunction of spleen dendritic cells and T-cells in zymosan-induced multiple organs dysfunction syndromes.
Liu Q; Lv Y; Zhao M; Jin Y; Lu J
Int J Clin Exp Pathol; 2015; 8(2):1374-83. PubMed ID: 25973021
[TBL] [Abstract][Full Text] [Related]
13. Interaction of programmed death-1 and programmed death-1 ligand-1 contributes to testicular immune privilege.
Cheng X; Dai H; Wan N; Moore Y; Vankayalapati R; Dai Z
Transplantation; 2009 Jun; 87(12):1778-86. PubMed ID: 19543053
[TBL] [Abstract][Full Text] [Related]
14. Programmed death-1 signaling is essential for the skin allograft protection by alternatively activated dendritic cell infusion in mice.
Dai H; Zhu H; Lei P; Yagita H; Liu J; Wen X; Zhou W; Gong F; Shen G; Fang M
Transplantation; 2009 Oct; 88(7):864-73. PubMed ID: 19935456
[TBL] [Abstract][Full Text] [Related]
15. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
Wang L; Han R; Hancock WW
Eur J Immunol; 2007 Oct; 37(10):2983-90. PubMed ID: 17899549
[TBL] [Abstract][Full Text] [Related]
16. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells.
Song S; Yuan P; Wu H; Chen J; Fu J; Li P; Lu J; Wei W
Int Immunopharmacol; 2014 May; 20(1):117-23. PubMed ID: 24606770
[TBL] [Abstract][Full Text] [Related]
18. Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1.
Lauden L; Boukouaci W; Borlado LR; López IP; Sepúlveda P; Tamouza R; Charron D; Al-Daccak R
Circ Res; 2013 Feb; 112(3):451-64. PubMed ID: 23243206
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
[TBL] [Abstract][Full Text] [Related]
20. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism.
Sugita S; Usui Y; Horie S; Futagami Y; Yamada Y; Ma J; Kezuka T; Hamada H; Usui T; Mochizuki M; Yamagami S
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):263-72. PubMed ID: 18775867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
